Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout

1. Executive Summary

Injective (INJ) has captured the spotlight this week with a stellar 15.26% price surge, breaking out of a multi-month descending channel. Positive developments, including the launch of its Ethereum Virtual Machine (EVM) testnet and a 1,500% spike in daily active addresses since January, have bolstered bullish sentiment. Despite some broader market weakness earlier in the week, Injective’s strong fundamentals and technical breakout signal promising upside potential.

2. Recent Market Developments

The past week has been eventful for Injective, with several key developments driving price activity:

• July 12, 2025: INJ surged 15.26%, breaking out of its bearish structure with renewed bullish momentum. Key resistance zones at $14.16 and $15.43 are now in focus as positive funding rates suggest strong trader conviction.
• July 11, 2025: Injective joined the broader market rally, trading near $13 after breaking its descending channel. A successful retest of the trendline could pave the way for sustained upside.
• July 9, 2025: Injective launched its EVM testnet, positioning itself as a leader in real-world asset (RWA) tokenization. This milestone coincided with a nearly 10x increase in daily active addresses over the past six months.
• July 6, 2025: On-chain usage spiked 1,500% since January, driving a quarterly price surge of 46.78%, with INJ defending the $10 level after reaching $15 in May.

While INJ experienced minor declines earlier in the week due to broader market pressures, its strong recovery and ecosystem growth have reinforced optimism among investors.

3. Technical Analysis

Injective’s price dynamics reflect a cautiously bullish trend, supported by robust technical indicators:

• Current Price: $12.57
• 24h High/Low: $13.16 / $12.06
• Moving Averages:
  • Short-term (SMA7: $11.37, EMA12: $11.42) indicate bullish momentum.
  • Long-term resistance lies above the SMA_200 at $13.33.
• Momentum Indicators:
  • RSI(14): 60.22, signaling moderate bullish strength.
  • MACD: Positive at 0.0836, with a histogram value of 0.2454, suggesting growing upward momentum.
• Bollinger Bands: With the price above the upper band (%B: 1.0717), INJ may face overbought conditions short-term but remains bullish overall.
• Key Levels:
  • Resistance 1: $13.16 (24h high).
  • Resistance 2: $15.48.
  • Support 1: $9.43.

The trend remains weakly bullish, with a breakout above $13.33 likely confirming a stronger move toward $15.

4. Trading Strategy and Signals

• Short-Term Traders: Monitor $13.16 for a potential breakout. A retest of the $12.60 pivot level could offer attractive entry points.
• Swing Traders: Look for sustained momentum above $13.33 (SMA_200) to target $15.48.
• Risk Management: Protect downside with stop-loss orders near $11.50, just below the EMA_12.

5. Price Predictions and Outlook

With Injective’s bullish breakout and key ecosystem updates, the outlook appears favorable:

• Short-Term Target: $13.16–$15.48, contingent on maintaining funding rates and bullish momentum.
• Medium-Term Target: A sustained move above $15 could set the stage for $18–$20, especially if ecosystem adoption accelerates.

However, broader macroeconomic conditions and crypto market sentiment remain key variables.

6. Risk Analysis

While Injective shows strong potential, risks persist:

• Market Volatility: Broader crypto market pressures could limit gains, as seen in the July 9 decline.
• Overbought Conditions: Technical indicators like RSI and Bollinger Bands suggest the possibility of short-term pullbacks.
• Macro Sentiment: External factors, including regulatory developments, could impact INJ’s trajectory.

Investors should exercise caution, particularly if INJ fails to hold above $12.60.

7. Conclusion

Injective has emerged as a standout performer, driven by its EVM testnet launch, increased on-chain activity, and a decisive breakout from bearish trends. With technical indicators signaling bullish momentum, INJ is well-positioned to target $15 and beyond in the near term. However, traders should remain vigilant, balancing optimism with prudent risk management strategies.

Injective’s innovative ecosystem and recent achievements make it a project to watch in 2025.

Image source: Shutterstock